Argan Stock Plummets -14% With 5-Day Losing Streak
Argan (AGX) – a provider of engineering and construction services for power generation – hit a 5-day losing streak, with cumulative losses over this period amounting to -14%. The company’s market cap has crashed by about $955 Mil over the last 5 days and currently stands at $5.7 Bil.
Is this opportunity or trap? There is not much to fear in AGX stock given its overall Strong operating performance and financial condition. This is aligned with the stock’s High valuation because of which we think it is Fairly Priced (For details, see Buy or Sell AGX).
But here is the interesting part. You are reading about this -14% move after it happened. The market has already priced in the news. To manage individual stock risk before the headlines, you need predictive signals, not notifications. High Quality Portfolio has a risk model designed to manage stock-specific drawdowns better.
Returns vs S&P 500
- SanDisk’s Surge Explained: What’s Fueling the Move?
- From Cyclical To Core: Vale’s Shift In 2026
- Why Booking Holdings’ Recent Selloff May Be Overdone
- Palantir At 80x Earnings: What Revenue Growth Rate Justifies The Valuation?
- Should You Pay Attention To Chevron Stock’s Momentum?
- What Is Happening With Caterpillar Stock?
The following table summarizes the return for AGX stock vs. the S&P 500 index over different periods, including the current streak:
| Return Period | AGX | S&P 500 |
|---|---|---|
| 1D | -6.1% | -1.7% |
| 5D (Current Streak) | -14.4% | -2.0% |
| 1M (21D) | -7.1% | -6.8% |
| 3M (63D) | 23.4% | -6.3% |
| YTD 2026 | 31.3% | -5.4% |
| 2025 | 130.6% | 16.4% |
| 2024 | 198.3% | 23.3% |
| 2023 | 30.2% | 24.2% |
Take a look at what history tells you about whether past dips like this have been buying opportunities or traps: AGX Dip Buyer Analysis.
Gains and Losses Streaks: S&P 500 Constituents
There are currently 66 S&P constituents with 3 days or more of consecutive gains and 39 constituents with 3 days or more of consecutive losses.
| Consecutive Days | # of Gainers | # of Losers |
|---|---|---|
| 3D | 20 | 26 |
| 4D | 37 | 5 |
| 5D | 6 | 3 |
| 6D | 3 | 1 |
| 7D or more | 0 | 4 |
| Total >=3 D | 66 | 39 |
Key Financials for Argan (AGX)
Last 2 Fiscal Years:
| Metric | FY2024 | FY2025 |
|---|---|---|
| Revenues | $573.3 Mil | $874.2 Mil |
| Operating Income | $36.5 Mil | $88.2 Mil |
| Net Income | $32.4 Mil | $85.5 Mil |
Last 2 Fiscal Quarters:
| Metric | 2026 FQ2 | 2026 FQ3 |
|---|---|---|
| Revenues | $237.7 Mil | $251.2 Mil |
| Operating Income | $30.1 Mil | $32.6 Mil |
| Net Income | $35.3 Mil | $30.7 Mil |
The losing streak AGX stock is currently on doesn’t inspire much confidence among investors. In contrast, Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 — the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.